Search for: "Sanofi-Aventis"
Results 41 - 60
of 561
Sort by Relevance
|
Sort by Date
16 Apr 2020, 6:00 am
Sanofi-Aventis U.S. [read post]
26 Mar 2020, 5:56 pm
Sanofi-Aventis U.S. [read post]
15 Mar 2020, 3:21 pm
As of the writing of this post, three of the largest insulin manufacturers – Eli Lilly, Novo Nordisk and Sanofi Aventis –have announced their intention to participate. [read post]
12 Mar 2020, 2:17 pm
Soon after that last article, a "Dear Healthcare Professional Letter" was sent out by sanofi-aventis Canada Inc., "LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions". [read post]
11 Dec 2019, 8:40 am
Zantac Class Action Lawsuits Recently, two class-action lawsuits were filed against Zantac manufacturer Sanofi-Aventis LLC and Boehringer Ingelheim Pharmaceuticals, who previously held rights to Zantac, with plaintiffs claiming that the companies knowingly put patient health at risk. [read post]
4 Nov 2019, 5:01 am
Sanofi-Aventis U.S. [read post]
24 Oct 2019, 9:24 am
A generic company recently invalidated a number of patents covering Lantus®—an insulin product that nets Sanofi-Aventis $15 million per day and has been the subject of numerous price hikes that far exceed inflation. [read post]
10 Oct 2019, 7:35 am
None of its largest corporations (such as LVMH, L'Oréal, and Sanofi-Aventis) is a digital-economy player. [read post]
8 Oct 2019, 1:37 am
Francois Pochart and Thierry LautierThe transposition of the “trade secrets” directive in France allowed the introduction of new legal tools that apply to ex parte investigation measures and infringement seizures (“saisie-contrefaçon”). [read post]
27 Aug 2019, 9:59 pm
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
26 Aug 2019, 4:15 am
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center of district court infringement litigation between the two parties. [read post]
26 Aug 2019, 4:15 am
Pfizer saw a lot of success last week in having seven IPRs instituted against Sanofi-Aventis, challenging four injectable insulin treatment patents that are at the center... [read post]
19 Aug 2019, 11:39 am
Sanofi-Aventis U.S. [read post]
12 Aug 2019, 12:32 am
Sanofi-Aventis Deutschland Gmbh). [read post]
27 Mar 2019, 11:33 am
Further comment was provided by Katfriend and Louboutin litigation expert Carina Gommers.PatentGuestKat Frantzeska Papadopoulou discusses the boundaries for Supplementary Protection Certificates (SPC) following the Swiss Tribunal decision between Genzyme Corporation (holder of supplementary protection certificate No C00716606/01), and its licensee, Sanofi-Aventis (holder of the authorizations for the products Renagel and Renvela)OtherGuestKat Ieva… [read post]
13 Feb 2019, 7:44 am
The two plaintiffs are Genzyme Corporation (holder of supplementary protection certificate No C00716606/01), and its licensee, Sanofi-Aventis (holder of the authorizations for the products Renagel and Renvela). [read post]
3 Jan 2019, 5:21 am
C00716606/01 (for the active ingredient sevelamer) and their exclusive licensee Sanofi-Aventis (Suisse) SA enforced their SPC against Swiss pharmaceutical company Salmon Pharma GmbH which had started marketing a generic version of Sanofi-Aventis’ medicament Renvela® containing the active ingredient sevelamer carbonate. [read post]
17 Oct 2018, 8:16 am
Minnesota Attorney General Lori Swanson filed a lawsuit Tuesday in the US District Court for the District of New Jersey alleging insulin manufacturers Sanofi-Aventis US, Novo Nordisk and Eli Lilly deceptively raised insulin prices. [read post]
29 Jun 2018, 7:50 am
In 2006, with the encouragement of Sanofi-Aventis, USP began to consider a standard for testing enoxaparin. [read post]
5 Feb 2018, 9:59 pm
Sanofi Aventis Deutschland GmbH PTAB Petition: IPR2017-01526; filed June 5, 2017. [read post]
